¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"giant retinal tear"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • foreign body giant cell
    À̹°°Å´ë¼¼Æ÷
  • giant
    1. °ÅÀÎ 2. °Å´ë-
  • giant axonal neuropathy
    °Å´ëÃà»è½Å°æº´(Áõ)
  • giant breast
    °Å´ëÀ¯¹æ
  • giant cell
    °Å´ë¼¼Æ÷
  • giant cell carcinoma
    °Å´ë¼¼Æ÷¾ÏÁ¾
  • giant cell epulis
    °Å´ë¼¼Æ÷Ä¡ÀºÁ¾
  • giant cell glioblastoma
    °Å´ë¼¼Æ÷¾Æ±³¸ð¼¼Æ÷Á¾, °Å´ë¼¼Æ÷±³¸ð¼¼Æ÷Á¾
  • giant cell granuloma
    °Å´ë¼¼Æ÷À°¾ÆÁ¾
  • giant cell myeloma
    °Å´ë¼¼Æ÷°ñ¼öÁ¾
  • giant cell myocarditis
    °Å´ë¼¼Æ÷½É±Ù¿°
  • giant cell pneumonia
    °Å´ë¼¼Æ÷Æó·Å
  • giant cell tumor
    °Å´ë¼¼Æ÷Á¾¾ç
  • giant colony
    °Å´ëÁý¶ô
  • giant condyloma
    °Å´ëÄܵô·Î¸¶
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • subependymal giant cell astrocytoma
    ³ú½Ç¸·¹Ø°Å´ë¼¼Æ÷º°¼¼Æ÷Á¾, »óÀÇÇϰŴ뼼Æ÷º°¼¼Æ÷Á¾
  • foreign body giant cell
    À̹°°Å´ë¼¼Æ÷
  • giant cell
    °Å´ë¼¼Æ÷
  • giant colony
    °Å´ëÁý¶ô
  • giant condyloma
    °Å´ëÄܵô·Î¸¶
  • giant cell carcinoma
    °Å´ë¼¼Æ÷¾ÏÁ¾
  • multinuclear giant cell
    ¹µÇÙ°Å´ë¼¼Æ÷
  • giant cell epulis
    °Å´ë¼¼Æ÷ÀÕ¸öÁ¾, °Å´ë¼¼Æ÷Ä¡ÀºÁ¾
  • giant
    °ÅÀÎ, °Å´ë-
  • giant hemangioma
    °Å´ëÇ÷°üÁ¾
  • giant metamyelocyte
    °Å´ë´Ê°ñ¼ö¼¼Æ÷
  • giant potential
    °Å´ëÀüÀ§
  • giant cell granuloma
    °Å´ë¼¼Æ÷À°¾ÆÁ¾
  • giant cell histiocytoma
    °Å´ë¼¼Æ÷Á¶Á÷±¸Á¾
  • giant cell myeloma
    °Å´ë¼¼Æ÷°ñ¼öÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • annular elastotic giant cell granuloma
    ȯ»ó ź·Â ¼¶À¯¼º °Å´ë¼¼Æ÷ À°¾ÆÁ¾
  • arteritis,giant cell of aorta
    ´ëµ¿¸Æ(ÓÞÔÑØæ)ÀÇ °Å¼¼Æ÷¼º(ËÝá¬øààõ)
  • giant
    °ÅÀÎ(ËÝìÑ).
  • giant
    °ÅÀÎ
  • giant bipolar
    °Å´ëÀ̱ؼ¼Æ÷(ËÝÓÞì£Ð¿á¬øà).
  • giant cell aortitis
    °Å´ë¼¼Æ÷¼º ´ëµ¿¸Æ¿°
  • giant cell arteritis
    °Å¼¼Æ÷(¼º) µ¿¸Æ¿°
  • giant cell arteritis=temporal arteritis
    °Å¼¼Æ÷µ¿¸Æ¿°
  • giant cell carcinoma
    °Å¼¼Æ÷¾ÏÁ¾
  • giant cell epulis
    °Å¼¼Æ÷Ä¡ÀºÁ¾.
  • giant cell fibroblastoma
    °Å´ë¼¼Æ÷ ¼¶À¯¸ð¼¼Æ÷Á¾
  • giant cell glioma
    °Å¼¼Æ÷±³Á¾.
  • giant cell granuloma
    °Å´ë¼¼Æ÷ À°¾ÆÁ¾
  • giant cell granuloma,reparative
    ¼öº¹¼º °Å´ë¼¼Æ÷ À°¾ÆÁ¾
  • giant cell histiocytoma
    °Å´ë¼¼Æ÷ Á¶Á÷±¸Á¾
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • tear drop sign
    ´«¹° ¹æ¿ï ¡ÈÄ
  • tear duct
    ´©°ü(רη).
  • tear film
    ´«¹°¸·, ´©¾×¸·
  • tear film breakup time
    ´«¹°¸·ÆÄ±«½Ã°£, ´©¾×¸·ÆÄ±«½Ã°£
  • tear flow
    ´«¹°È帧, ´©¾×·ù
  • tear gas
    ÃÖ·ç(õÊר)°¡½º.
  • tear meniscus
    ´«¹°¶ì
  • tear resistance
    Àο­ÀúÇ×(ìÚæñî½ù÷).
  • tear sac
    ´©³¶(רҥ).
  • tear sac
    ´«¹°ÁÖ¸Ó´Ï, ´©³¶(רҥ).
  • tear secretion
    ´«¹°ºÐºñ, ´©¾×ºÐºñ
  • tear stone
    ´©µµ°á¼®, ´©¼®(רà´).
  • tear stone
    ´©¼®(רà´)
  • tear tester
    Àο­½ÃÇè±â(ìÚæñãËúÐÐï).
  • wear and tear
    ¼Ò¸ð(á¼ÙÄ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RCT radiotherapy and chemotherapy; randomized clinical trial; randomized controlled trial; registered ca...
GIP   1) Giant cell Interstitial Pneumonia
  2) Gastric Inhibitory (Poly)Peptide
HARH High Altitude Retinal Hemorrhage
IRMA   1) Intra-Retinal Microvascular Abnormalities
  2) Immuno-Radio-Metric Assay...
PRP   1) Progressive Rubella Panencephalitis
  2) Platelet Rich Plasma
 &...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GAN Giant Axonal Neuropathy
GCA Giant Cell Arteritis
GCF Giant Cell Fibroblastoma
GCT Giant Cell Tumor
GF Giant Fiber
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lamellar retinal hole
    Ç¥Ãþ ¸Á¸· ¿­°ø
  • occlusive retinal vasculopathy
    Æó¼â¼º ¸Á¸· Ç÷°üÁõ
    Á᫐ ¸Á¸· µ¿¸ÆÀÇ Æó¼â·Î ÀÎÇÑ ³»¸Á¸· °æ»öÀ¸·Î ¿µ±¸Àû ½Ã·Â ¼Ò½ÇÀÌ ¹ß»ýÇÑ´Ù. ¾ÈÀú °Ë»ç´Â Á¤¸Æ Ç÷·ùÀÇ Á÷»ç°¢ÇüÀÇ À¯°³ ¿­Â÷ ¸ð¾çÀÇ ºÐÀýÈ­¿Í ½Å°æÀý ¼¼Æ÷ Ãà»è¿¡¼­ Ãà»è ÇüÁúÀÇ ¿ïÇ÷·Î ÀÎÇÑ ºÒÅõ¸íÇÑ ¹é»ö ¸Á¸·ÀÌ º¸¿©Áø´Ù. Á᫐ ¼±È«»ö ¹ÝÁ¡Àº Ãà»èÀÌ ¾ø´Â Ȳ¹ÝºÎ¿¡ ¸Æ¶ô¸·ÀÌ º¸¿©ÁüÀ¸·Î½á ¹ß»ýÇÑ´Ù.
  • perineal tear
    ȸÀ½ ¿­»ó
  • retinal
    ¸Á¸·ÀÇ
    1. ¸Á¸·¿¡ °üÇÑ. 2. ·¹Æ¼³îÀº ¾Ëµ¥ÇÏÀ̵å·Î¼­ À½½Ä¹°¿¡¼­ Èí¼öµÈ Ä«·ÎƾÀÌ »êÈ­ È¿¼Ò¿¡ ÀÇÇØ ºÐÇØµÇ¾î Çü¼ºµÇ¸ç, ºñŸ¹Î AÀÇ È°¼ºÀ» °¡Áø´Ù. ¸Á¸· ³»¿¡¼­ ·¹Æ¼³¯Àº ¿É½Å°ú °áÇÕÇÏ¿© °¨±¤ »ö¼Ò¸¦ Çü¼ºÇÑ´Ù. À̼ºÃ¼ÀÇ ÀÏÁ¾ÀÎ 11-cis retinalÀº °£»óü ÁßÀÇ ¿É½Å°ú °áÇÕÇÏ¿©, ·Îµ½½Å ¶Ç´Â ½ÃÈ«À» Çü¼ºÇÑ´Ù. ´Ù¸¥ À̼ºÃ¼ÀÎ 11- trans retinalÀº ·Îµ½½ÅÀÌ ºû¿¡ ÀÇÇÏ¿© Åð»öÇÏ¿© »ý±â¸ç, ¿©±â¿¡¼­ 11-cis ÇüÀÌ 11-trans ÇüÀ¸·Î ÀüȯµÈ´Ù. ·¹Æ¼³¯Àº ¿øÃßüÀÇ ¿É½Å°úµµ °áÇÕÇÏ¿© »ö°¢¿¡ °ü¿©ÇÏ´Â 3Á¾ÀÇ »ö¼Ò¸¦ Çü¼ºÇÑ´Ù.
  • retinal cell
    ¸Á¸· ¼¼Æ÷
  • retinal detachment
    ¸Á¸· ¹Ú¸®
  • retinal infiltrate
    ¸Á¸· ħÀ±
  • retinal neurocytoma
    ¸Á¸· ½Å°æ ¼¼Æ÷Á¾
  • retinal vasculopathy
    ¸Á¸· Ç÷°üº´Áõ
    1´Ü°è´Â ¼Òµ¿¸ÆÀÇ ÇùÂø, 2´Ü°è´Â µ¿Á¤¸Æ ÇÔ¿ä, ¼Ò·®ÀÇ »ïÃâ, ±×¸®°í ¼±»ó ÃâÇ÷¹Ý, 3´Ü°è´Â ¸Á¸· ºÎÁ¾, ÃâÇ÷, ±×¸®°í ¸éÈ­¹Ý, ½Å°æ ¼¶À¯Ãþ ³» ±¹¼Ò ÇãÇ÷, 4´Ü°è´Â 3´Ü°èÀÇ º¯È­¿Í ÇÔ²² À¯µÎ ºÎÁ¾ÀÌ´Ù.
  • retinal vein obstruction
    ¸Á¸· Á¤¸Æ Æó¼â
  • serous retinal detachment
    Àå¾×¼º ¸Á¸· ¹Ú¸®
  • tear drop sign
    ´«¹° ¹æ¿ï ¡ÈÄ, ³«·ç ¡ÈÄ
  • tear film
    ´«¹°¸·, ´©¾×¸·
  • tear flow
    ´«¹° È帧, ´©¾×·ù
  • tear meniscus
    ´«¹° ¶ì
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
central retinal fovea A depression in the centre of the macula retinae containing only cones and lacking blood vessels.
Synonym: fovea centralis retinae, central pit.
(05 Mar 2000)
central retinal vein occlusion <ophthalmology> The sudden blockage of the retinal vein with blood clot that commonly leads to a painless irreversible blindness in that eye.
(12 Jan 1998)
retinal 1. <anatomy> Pertaining to the retina.
2. <biochemistry> The aldehyde of retinol, derived by the oxidative enzymatic splitting of absorbed dietary carotene and having vitamin A activity. In the retina, retinal combines with opsins to form visual pigments. One isomer, 11 cis retinal combines with opsin in the rods (scotopsin) to form rhodopsin or visual purple. Another, all trans retinal (trans r.), visual yellow, xanthopsin) results from the bleaching of rhodopsin by light, in which the 11 cis form is converted to the all trans form. Retinal also combines with opsins in the cones (photopsins) to form the three pigments responsible for colour vision.
(18 Nov 1997)
retinal adaptation Adjustment to degree of illumination.
(05 Mar 2000)
retinal anlage tumour A benign neoplasm of neuroectodermal origin that most often involves the anterior maxilla of infants in the first year of life. It presents clinically as a rapidly growing blue-black lesion producing a destructive radiolucency; histologically, it is characterised by small round undifferentiated tumour cells interspersed with larger polyhedral melanin-producing cells arranged in an alveolar configuration.
Synonym: melanoameloblastoma, pigmented ameloblastoma, pigmented epulis, progonoma of jaw, retinal anlage tumour.
(05 Mar 2000)
retinal artery <anatomy, artery> Central retinal artery and its branches. It arises from the ophthalmic artery, pierces the optic nerve and runs through its centre, enters the eye through the porus opticus and branches to supply the retina.
(12 Dec 1998)
retinal artery occlusion Occlusion or closure of the central retinal artery causing sudden, usually nearly complete, loss of vision in one eye. Occlusion of the branch retinal artery causes sudden visual loss in only a portion of the visual field.
(12 Dec 1998)
retinal blood vessels The blood vasculature of the retina, including the branches and tributaries of the central retinal artery and vein, respectively, and the vascular circle of the optic nerve.
Synonym: vasa sanguinea retinae.
(05 Mar 2000)
retinal camera An instrument for photographing the ocular fundus.
(05 Mar 2000)
retinal cone <ophthalmology, physiology> One of the two photoreceptor cell types in the vertebrate retina.
In cones the photopigment is in invaginations of the cell membrane of the outer segment. Cones are less sensitive to light than rods, and are differentially sensitive to particular wavelengths of light and therefore important for colour vision.
They provide vision with higher spatial and temporal acuity, and it is the combination of signals from cones with different pigments that facilitates colour vision. There are three types of cones, each type sensitive to red, green or blue. Present in large numbers in the fovea.
(03 Jul 1999)
retinal degeneration <ophthalmology> A retrogressive pathological change in the retina, focal or generalised, caused by genetic defects, inflammation, trauma, vascular disease, or aging.
Degeneration affecting predominantly the macula lutea of the retina is macular degeneration.
(03 Jul 1999)
retinal dehydrogenase An oxidoreductase catalyzing the interconversion of retinaldehyde and NAD+ to retinoic acid and NADH; thus affecting growth and differentiation.
Synonym: retinaldehyde dehydrogenase.
(05 Mar 2000)
retinal detachment <ophthalmology> A painless disorder (when spontaneous) where the patient complains of a gradual raising or lowering of a curtain over the visual field of the affected eye. May also occur as the result of trauma.
(27 Sep 1997)
retinal disease <ophthalmology> A general term which describes any retinal changes (haemorrhages or exudates) that can affect vision (for example diabetic retinopathy, hypertensive retinopathy).
(27 Sep 1997)
retinal disparity The slight difference in retinal images that arises because of the lateral separation of the two eyes that stimulates stereoscopic vision.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • giant star
    °Å¼º(Á÷°æ,±¤µµ,Áú·®)µîÀÌ ÇöÀúÇÏ°Ô Å« Ç×¼º
  • giant swing
    (öºÀÀÇ)´ëÂ÷·û 
  • giant(s) stride
    ȸÀü ±×³×
  • red giant
    Àû»ö °Å¼º(Ç¥¸é ¿Âµµ°¡ ³·°í ºÓ°Ô ºû³ª´Â Å« º°)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á